{
    "clinical_study": {
        "@rank": "10",
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on April 07, 2020",
            "link_text": "Link to the current ClinicalTrials.gov record.",
            "url": "https://clinicaltrials.gov/show/NCT04333420"
        },
        "id_info": {
            "org_study_id": "IFX-1-P2.9",
            "nct_id": "NCT04333420"
        },
        "brief_title": "Open-label, Randomized Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",
        "acronym": "PANAMO",
        "official_title": "A Pragmatic Adaptive Open Label, Randomized Phase II/III Multicenter Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",
        "sponsors": {
            "lead_sponsor": {
                "agency": "InflaRx GmbH",
                "agency_class": "Industry"
            }
        },
        "source": "InflaRx GmbH",
        "oversight_info": {
            "has_dmc": "Yes",
            "is_fda_regulated_drug": "Yes",
            "is_fda_regulated_device": "No"
        },
        "brief_summary": {
            "textblock": "This is a pragmatic, adaptive, open-label, randomized, multicenter phase II/III study\n      consisting of two parts: Phase II and Phase III. In both study parts, patients will be\n      randomized to two treatment arms (Arm A: best supportive care [BSC] + IFX-1; Arm B: BSC\n      alone). After all patients are treated in Phase II, an interim analysis will be performed to\n      assess the clinical benefit of the treatment using the assessed clinical parameters."
        },
        "overall_status": "Recruiting",
        "start_date": {
            "@type": "Actual",
            "#text": "March 31, 2020"
        },
        "completion_date": {
            "@type": "Anticipated",
            "#text": "December 31, 2020"
        },
        "primary_completion_date": {
            "@type": "Anticipated",
            "#text": "October 31, 2020"
        },
        "phase": "Phase 2/Phase 3",
        "study_type": "Interventional",
        "has_expanded_access": "No",
        "study_design_info": {
            "allocation": "Randomized",
            "intervention_model": "Parallel Assignment",
            "primary_purpose": "Treatment",
            "masking": "None (Open Label)"
        },
        "primary_outcome": {
            "measure": "Change in PaO2/FiO2",
            "time_frame": "Baseline to Day 5",
            "description": "Relative change (%) from baseline in Oxygenation Index (PaO2 / FiO2) to day 5."
        },
        "secondary_outcome": {
            "measure": "Patients achieving early response",
            "time_frame": "Baseline to Day 7",
            "description": "Number of patients (%) achieving an Early Response"
        },
        "number_of_arms": "2",
        "enrollment": {
            "@type": "Anticipated",
            "#text": "130"
        },
        "condition": "COVID-19 Pneumonia",
        "arm_group": [
            {
                "arm_group_label": "Arm A: BSC + IFX-1",
                "arm_group_type": "Experimental"
            },
            {
                "arm_group_label": "Arm B : BSC only",
                "arm_group_type": "Experimental"
            }
        ],
        "intervention": [
            {
                "intervention_type": "Drug",
                "intervention_name": "Best supportive Care (BSC) + IFX-1",
                "description": "Best supportive care [BSC] + IFX-1",
                "arm_group_label": "Arm A: BSC + IFX-1"
            },
            {
                "intervention_type": "Drug",
                "intervention_name": "Best supportive care only",
                "description": "Best supportive care only",
                "arm_group_label": "Arm B : BSC only"
            }
        ],
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  At least 18 years of age or older\n\n          -  Clinically evident or otherwise confirmed severe pneumonia\n\n          -  SARS-CoV2 infection confirmation (tested positive in last 14 days or test results to\n             be obtained within 24h after enrollment, both with locally available test system).\n\n        Exclusion Criteria:\n\n          -  Known history of COPD\n\n          -  Received new other biologic treatment attempt for COVID-19 in the past 14 days\n\n          -  Received treatment with a viral replication inhibitor in past 3 days\n\n          -  Received organ or bone marrow transplantation in past 3 months\n\n          -  Known mechanically resuscitation in past 14 days\n\n          -  Known severe congestive heart failure (NYHA-Class III - IV)"
            },
            "gender": "All",
            "minimum_age": "18 Years",
            "maximum_age": "N/A",
            "healthy_volunteers": "No"
        },
        "overall_official": {
            "last_name": "A Vlaar, MD",
            "role": "Principal Investigator",
            "affiliation": "University Amsterdam"
        },
        "overall_contact": {
            "last_name": "Korinna Pilz, MD",
            "phone": "+49 89 4141 89 78",
            "phone_ext": "0",
            "email": "korinna.pilz@inflarx.de"
        },
        "location": {
            "facility": {
                "name": "University Amsterdam",
                "address": {
                    "city": "Amsterdam",
                    "zip": "1105",
                    "country": "Netherlands"
                }
            },
            "status": "Recruiting",
            "contact": {
                "last_name": "A. V., MD, PhD"
            }
        },
        "location_countries": {
            "country": "Netherlands"
        },
        "verification_date": "April 2020",
        "study_first_submitted": "April 1, 2020",
        "study_first_submitted_qc": "April 1, 2020",
        "study_first_posted": {
            "@type": "Actual",
            "#text": "April 3, 2020"
        },
        "last_update_submitted": "April 3, 2020",
        "last_update_submitted_qc": "April 3, 2020",
        "last_update_posted": {
            "@type": "Estimate",
            "#text": "April 7, 2020"
        },
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        },
        "keyword": "COVID-19 related severe pneumonia",
        "condition_browse": {
            "mesh_term": "Pneumonia"
        },
        "patient_data": {
            "sharing_ipd": "No"
        }
    }
}